Empery Asset Management »

Annovis Bio shares owned by Empery Asset Management

Quarter-by-quarter ownership of Annovis Bio (ANVS) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Annovis Bio

Tip: Access up to 7 years of quarterly data

All positions including Annovis Bio held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annovis Bio by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.5M 2.4M 1.86

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Nervgen Pharma Ord (NGEN)
Precision Biosciences Com New (DTIL)
Clene Com New (CLNN)
Annovis Bio (ANVS)
Lantern Pharma (LTRN)
Amc Entmt Hldgs Cl A New (AMC)
Tenaya Therapeutics (TNYA)
One And One Green Technologi Usd Cl A Ord Shs (YDDL)
Cyngn Inc Com Par $0 00001 (CYN)
Venu Hldg Corp (VENU)
Greenland Energy *w Exp 04/21/203
Ur-energy (URG)
Satellos Bioscience (MSLE)

View all positions for Empery Asset Management

Top funds holding Annovis Bio

Empery Asset Management
Marshall Wace
Vanguard Capital Management
Two Sigma Investments
Susquehanna International
Renaissance Technologies
Geode Capital Management
Northern Trust
BlackRock
Vanguard Fiduciary Trust
Citadel Advisors
Jane Street
State Street Corporation
Group One Trading
First National Trust Company

View all funds holding Annovis Bio